Cencora (COR) DIvidends Date & History

Key Takeaways

• Cencora maintains a conservative dividend yield of 0.77% with an annual payout of $2.40 per share.
• The company pays dividends quarterly at $0.60 per share, supported by a low payout ratio of approximately 18%.
• Dividend payments have shown consistent growth over more than two decades, backed by strong free cash flow.
• Earnings and cash flow coverage indicate high sustainability for future dividend increases.
• The stock appeals primarily to long-term investors seeking moderate income with growth potential.
• Relative to healthcare distribution peers, the yield is modest but offers room for expansion.

Dividend Overview

Cencora, Inc. (COR) follows a quarterly dividend policy typical of established healthcare companies. The current dividend yield stands at 0.77%, with an annualized dividend of $2.40 per share or $0.60 quarterly. This profile positions Cencora as a dividend growth stock rather than a high-yield option. The modest yield reflects a focus on reinvestment and share repurchases alongside shareholder returns. Payments have remained consistent, aligning with the company's strong financial position in pharmaceutical distribution.

Dividend History and Growth

Cencora has a 23-year dividend history marked by steady increases. The annual dividend has grown over time, with recent quarterly payments holding at $0.60 per share. The company has avoided cuts and demonstrated resilience through economic cycles. Growth trends show measured annual raises supported by expanding operations and profitability. This long-term consistency appeals to investors tracking dividend growth streaks in the healthcare sector.

Dividend Sustainability and Payout Ratio

The dividend appears highly sustainable given the low payout ratio of around 18%. This leaves substantial earnings available for reinvestment or further increases. Free cash flow remains robust, with recent annual figures exceeding $3 billion, providing ample coverage for the current payout. Debt levels are managed prudently, and overall financial stability supports ongoing distributions. Analysts note coverage by both earnings and cash flows, reducing risk of future adjustments.

Dividend Compared to Industry Peers

Within the healthcare distribution sector, Cencora's yield of 0.77% sits below some peers that offer higher current income. Competitors in pharmaceutical wholesaling often feature yields in a similar modest range, emphasizing growth over immediate high payouts. Cencora's lower payout ratio provides greater flexibility compared to higher-yielding names, potentially allowing for stronger future growth relative to industry averages.

AI Screener

Tickeron’s AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener helps identify dividend stocks, income-focused investments, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. Explore opportunities with the AI Screener.

Is This Stock Attractive for Dividend Investors?

Cencora may suit long-term dividend growth investors who prioritize sustainability and modest current income over high yields. The low payout ratio and strong cash flow position it well for gradual increases, appealing to those building positions over time. Conservative investors focused on healthcare stability could find value in its consistent payments and sector resilience. Income-oriented investors seeking higher yields might look elsewhere, while growth-focused shareholders benefit from the balance of dividends and reinvestment. The stock offers analytical appeal without aggressive income generation.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations